Suchergebnisse - "Hess, Lisa M."

PubPharm (11)

1

Initial versus early switch to targeted therapy during first-line treatment among patients with biomarker-positive advanced or metastatic non-small cell lung cancer in the United States

enthalten in: Cancer treatment and research communications | 2023

von Hess, L. | Peterson, P. | Sugihara, T. | +3

2

Efficacy of immune checkpoint inhibitor therapy in patients with RET fusion-positive non-small-cell lung cancer

enthalten in: Immunotherapy | 2021

von Bhandari, N. | Hess, L. | Han, Y. | +2

3

Treatment patterns for patients with advanced/metastatic cancers by site of care

enthalten in: The American journal of managed care | 2021

von Bunniran, S. | Xu, Y. | Molife, C. | +5

4

Treatment sequencing for the care of patients with advanced or metastatic non-small cell lung cancer in the United States

enthalten in: Current medical research and opinion | 2021

von Hess, L. | Cui, Z. | Li, X. | +2

5

Health care resource utilization and treatment variability in the care of patients with advanced or metastatic colorectal or gastric cancer

enthalten in: Journal of medical economics | 2021

von Hess, L. | Zhu, Y. | Fang, Y. | +1

6

Characteristics and outcomes of patients with RET-fusion positive non-small lung cancer in real-world practice in the United States

enthalten in: BMC cancer | 2021

von Hess, L. | Han, Y. | Zhu, Y. | +2

ErratumIn: BMC Cancer. 2023 Apr 26;23(1):382. - PMID 37101117

7

Sequential therapy with ramucirumab and/or checkpoint inhibitors for non-small-cell lung cancer in routine practice

enthalten in: Future oncology (London, England) | 2019

von Molife, C. | Hess, L. | Cui, Z. | +4

8

Treatment patterns and survival outcomes for patients receiving second-line treatment for metastatic colorectal cancer in the USA

enthalten in: International journal of colorectal disease | 2019

von Hess, L. | Cui, Z. | Mytelka, D. | +3

9

Real-World Outcomes and Factors Associated With the Second-Line Treatment of Patients With Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma

enthalten in: Cancer control : journal of the Moffitt Cancer Center | 2019

von Barzi, A. | Hess, L. | Zhu, Y. | +4

10

Ramucirumab for the treatment of patients with gastric or gastroesophageal junction cancer in community oncology practices

enthalten in: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association | 2018

von Paulson, A. | Hess, L. | Liepa, A. | +4